DSIP 15mg

Delta Sleep-Inducing Peptide (DSIP) is a nonapeptide often sold in 15mg lyophilized (freeze-dried) vials for research, designed to modulate sleep cycles, increase slow-wave sleep, and act as a neuroprotective agent. It is primarily studied for treating insomnia, chronic stress, and fatigue, but it is not FDA-approved and often listed as a restricted, research-only substance.

Key Aspects of 15mg DSIP:

• Research Applications: DSIP is studied for reducing sleep latency (time to fall asleep), increasing sleep quality, reducing anxiety, and improving adaptation to stress.
• Mechanism: It is believed to act on the central nervous system, particularly influencing GABA and modulating delta-wave EEG activity, which is associated with deep, restorative sleep.
• Formulation: 15mg vials usually contain a lyophilized powder, which is typically reconstituted with bacteriostatic water for laboratory use.
• Status: It is not FDA-approved for human consumption and is often categorized as a research compound.